What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Krsnaa Diagnostics Limited IPO?

Krsnaa Diagnostics Limited IPO has received a total subscription of 0.00 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Krsnaa Diagnostics Limited

ListedMainboard

Industrial & Financial Services · NSE / BSE

Incorporated in 2010, Krsnaa Diagnostics Ltd is one of India’s fastest-growing diagnostic chains, offering a wide range of services including imaging/radiology (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology to hospitals, medical colleges, and community health centres. The company has a strong presence in non-metro and lower-tier cities, operating 1,801 diagnostic centres across 13 cities as of December 31, 2020. In fiscal 2020, Krsnaa Diagnostics served approximately 5.27 million patients.

Price Band

₹933 – ₹954

Issue Size

₹1213 Cr

Lot Size

15 shares

GMP

₹222

+23.3%

Est. Listing

₹1176

at current GMP

Subscribed

—

Open

4 Aug 2021

6 Aug 2021

Allotment

12 Aug 2021

Refund

13 Aug 2021

Demat Credit

14 Aug 2021

Listing

16 Aug 2021

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

0.00x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 0.00x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	6,357,442	—	0.00x
Non-Institutional (NII / HNI)	1,907,233	—	0.00x
Retail Individual (RII)	4,450,210	—	0.00x
Total	12,714,885	0	0.00x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.00x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	296,681	296,681	1.00x
HNIs (10L +)	1,898	1,898	1.00x
HNIs (2-10L)	9,082	9,082	1.00x
Total Applications	307,661	307,661	1.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Krsnaa Diagnostics Limited Public Issue & Market Profile

Krsnaa Diagnostics Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹1,213 Crores. The shares are offered at a price band of ₹933 to ₹954 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2021-08-06, the basis of allotment is scheduled to be finalized on 2021-08-12. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Krsnaa Diagnostics Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Krsnaa Diagnostics Limited IPO is ₹222 per equity share. Based on the upper price band of ₹933 to ₹954 per equity share, the estimated listing price is ₹1176 (+23.3% expected listing gain).

What is the expected profit per lot for Krsnaa Diagnostics Limited IPO?

With a lot size of 15 shares and current GMP of ₹222, the expected profit per application lot is approx ₹3,330 (+23.3% gain). Minimum application cost is approx ₹14,310.

What is the issue size and price band for Krsnaa Diagnostics Limited IPO?

The Krsnaa Diagnostics Limited IPO aggregate issue size is ₹1,213 Crores with an equity price band set at ₹933 to ₹954 per equity share. The retail lot size is 15 shares requiring a minimum capital outlay of approx. ₹14,310.

How can I check Krsnaa Diagnostics Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Krsnaa Diagnostics Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2021-08-12. Investors can verify status using PAN card or application number.

When is the listing date for Krsnaa Diagnostics Limited IPO?

Krsnaa Diagnostics Limited shares are scheduled to list on NSE and BSE on 2021-08-16.